CBX3 and neoplasm: NB-9464 tumor cells were implanted in wt mice, on day 12 or 14 after implantation, mice were treated with in vitro-activated wt or Cbx3/HP1γ-insufficient CD8+ T cells, and tumor growth was monitored until day 31.